SLILATY STEVE N. (Chief Executive Officer) reported 1 transaction at SUNSHINE BIOPHARMA INC.
Review the transaction codes below to understand the nature of each event.
Filed: 2/22/2022ACC: 0001683168-22-001185
DirectorOfficer· Chief Executive Officer
Since Aug 2018
-990K
Net shares
Net seller
$99.0K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
990K disposed
Non-Derivative Transactions1
Series B Preferred Stock
Direct
Shares
−990K
Price / share
$0.10
Trade value
$99K
% of position
99.0%
2/18/2022
1M→10K
Total
Net shares
−990K
Net value
-$99K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Series B Preferred Stock Direct | 2/18/2022 | D · Disposition | −990K | $0.10 | $99K | 99.0% | 1M | 10K |
| Total | −990K | -$99K | ||||||
Derivative Transactions0
No derivative transactions reported